HUMAN RESEARCH DURING COVID
Researchers should refer to U-M Environment, Health & Safety COVID-19 Information for updated guidance and policies related to working and conducting research while COVID-19 remains a public health concern. The policies apply to research in all settings, both on and off campus.
For guidance specific to Michigan Medicine research and clinical operations, refer to the Power of Prevention COVID-19 resource page.
Questions? Contact email@example.com.
CLINICAL TRIALS SUPPORT OFFICE
The Clinical Trials Support Office (CTSO) is the central hub for the seven trans-departmental Clinical Trials Support Units (CTSUs), providing enterprise-wide leadership, standards, policies, and a common infrastructure. At Michigan Medicine, all NIH-defined clinical trials and clinical research that has a billing calendar are required to be supported by a CTSU.
In our role as concierge for clinical research, we act as a liaison between Principal Investigators and study teams to other partners across the U-M involved in clinical research. CTSO team members, also support OnCore, our integrated and comprehensive clinical trials management system.
Easier and more timely navigation through the administrative processes of clinical research at Michigan Medicine is our goal. If you are a faculty or study team member, CLICK HERE to start the clinical research process, or connect with us at CTSOgroup@umich.edu.
>>Not sure if your study is a Clinical Trial? Click here to view the NIH definition of a Clinical Trial.
CTSO METRICS: FY2021
During Fiscal Year 2021, over 66,511 patients participated in active clinical research studies at the CTSO. Of those studies that were open to enrollment, 41% were funded by industry, 15% funded nationally, 14% funded externally/peer-reviewed, and 17% were funded institutionally.